Nonmalignant Hematology

CCO&rsquo s expert faculty review and share their expert perspectives on key findings in nonmalignant hematologic disorders presented at the 2019 ASH annual meeting.

Share

Program Content

Activities

  • Nonmalignant Heme Commentary
    Nonmalignant Hematologic Disorders: Key Trials From ASH 2019
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 18, 2020

    Expires: February 16, 2021

Activities

PRN1008 in ITP
Phase I/II Evaluation of Novel BTKi PRN1008 in R/R Primary or Secondary Immune Thrombocytopenia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2019

Expires: December 08, 2020

Avatrombopag In ITP
Updated Results From a Randomized Phase III Trial of Avatrombopag in Patients With Chronic ITP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2019

Expires: December 09, 2020

SCD: <i>BCL11A</i> Gene Therapy
Pilot Feasibility Study of BCL11A as Gene Therapy Target in Sickle Cell Disease
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2019

Expires: December 11, 2020

CARDINAL: Sutimlimab for CAD
CARDINAL: Phase III Study of Sutimlimab in Patients With Cold Agglutinin Disease and a Recent History of Transfusion
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2019

Expires: December 13, 2020

Northstar-3 (HGB-212)
Interim Results From the Phase III Northstar-3 (HGB-212) Study of Betibeglogene Autotemcel in Patients With Severe Transfusion-Dependent β-Thalassemia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2019

Expires: December 15, 2020

BELIEVE Subanalysis
BELIEVE Subanalysis: Evaluation of Responders With Transfusion-Dependent β-Thalassemia to Luspatercept
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2019

Expires: December 15, 2020

Sutimlimab in Chronic ITP
Phase I Trial of Sutimlimab to Inhibit Classical Complement Pathway in Patients With Multi-Refractory Chronic Immune Thrombocytopenia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2019

Expires: December 16, 2020

Faculty

cover img faculity

Hanny Al-Samkari, MD

Assistant Professor
Harvard Medical School
Attending Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Sujit Sheth, MD

Professor
Department of Pediatrics
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Supporters

AstraZeneca

Celgene

Dova Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Loxo Oncology subsidiary of Eli Lilly

Pharmacyclics an AbbVie Company